Brisbane Clinical Trials
The Treat COVID Study
The purpose of this study is testing a potential new treatment for COVID-19.
8 nights
8 visits
The study drug is based on antibodies that have been engineered to treat COVID-19 more efficiently. This study drug is expected to block viral entry and ultimately prevent viral infection. While there are approved vaccines and treatments, there is an ongoing need for the development of new treatments, especially considering the different variants that have emerged.
The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.
Call us on 1800 243 733 to discuss your eligibility today!
Eligibility
Biological Sex Healthy males and females
Age 18 – 55 years old, inclusive
BMI 18 - 32 kg/m²
Body Weight Males: ≥ 50kg Females: ≥ 45kg
Medical History No significant medical history
Medications Not taking any medication
Smoking History Non-smokers or smokers who smoke < than 10 per week in the last 6 weeks